ReviewCancer gene therapy2002
Selectively replicating viral vectors.
Review in Cancer gene therapy, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Editorial: Oncolytic virotherapy.Frontiers in molecular biosciences · 2023Article
- Overexpression of LncRNAOncoTargets and therapy · 2020Article
- A novel approach to glioma therapy using an oncolytic adenovirus with two specific promoters.Oncology letters · 2018Article
- Pigmy MicroRNA: surveillance cops in Therapies kingdom.Molecular medicine (Cambridge, Mass.) · 2016Article
- Clinical development directions in oncolytic viral therapy.Cancer gene therapy · 2011Review
- Coronavirus genetically redirected to the epidermal growth factor receptor exhibits effective antitumor activity against a malignant glioblastoma.Journal of virology · 2009Article
- An acute toxicology study with INGN 007, an oncolytic adenovirus vector, in mice and permissive Syrian hamsters; comparisons with wild-type Ad5 and a replication-defective adenovirus vector.Cancer gene therapy · 2009Article
- Herpes simplex virus type-1(HSV-1) oncolytic and highly fusogenic mutants carrying the NV1020 genomic deletion effectively inhibit primary and metastatic tumors in mice.Virology journal · 2008Article
- The nitroreductase prodrug SN 28343 enhances the potency of systemically administered armed oncolytic adenovirus ONYX-411(NTR).Cancer gene therapy · 2007Article
- p53-expressing conditionally replicative adenovirus CNHK500-p53 against hepatocellular carcinoma in vitro.World journal of gastroenterology · 2007Article
- Herpes simplex virus 1 (HSV-1) for cancer treatment.Cancer gene therapy · 2006Review
- Future prospects for oncolytic therapy.Oncogene · 2005Article
- Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomas.Cancer research · 2005Article
- Oncolytic viral therapies.Cancer gene therapy · 2004Review
- Improved gene transfer selectivity to hepatocarcinoma cells by retrovirus vector displaying single-chain variable fragment antibody against c-Met.Cancer gene therapy · 2003Article
- Virotherapy for cancer: current status, hurdles, and future directions.Cancer gene therapy · 2002Article
- Characterization of an Oncolytic Adenovirus Vector Constructed to Target the cMet Receptor.Oncolytic virotherapyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
12522438What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.